Articles with "coti" as a keyword



Photo by art_almighty from unsplash

COTI-2 induces cell apoptosis in pediatric acute lymphoblastic leukemia via upregulation of miR-203

Sign Up to like & get
recommendations!
Published in 2020 at "Bioengineered"

DOI: 10.1080/21655979.2020.1729927

Abstract: ABSTRACT COTI-2 is a third-generation thiosemicarbazone, which is effective against a diverse group of human cancer cell lines at nanomolar concentrations. COTI-2 also showed superior activity against tumor cells, in vitro and in vivo. As… read more here.

Keywords: coti; cell apoptosis; mir 203; jurkat cells ... See more keywords
Photo by thanti_riess from unsplash

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

Sign Up to like & get
recommendations!
Published in 2018 at "PLoS ONE"

DOI: 10.1371/journal.pone.0191766

Abstract: Emerging drug-resistance and drug-associated toxicities are two major factors limiting successful cancer therapy. Combinations of chemotherapeutic drugs have been used in the clinic to improve patient outcome. However, cancer cells can acquire resistance to drugs,… read more here.

Keywords: cross resistance; coti; drug; exhibit cross ... See more keywords
Photo by kdghantous from unsplash

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14184455

Abstract: Simple Summary Besides zinc, also iron and copper need to be considered to play a role in the mode of action and resistance development of the anticancer thiosemicarbazone COTI-2 and its derivatives. One of these… read more here.

Keywords: copper; besides zinc; resistance; coti ... See more keywords
Photo from wikipedia

Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants

Sign Up to like & get
recommendations!
Published in 2023 at "Genes"

DOI: 10.3390/genes14030747

Abstract: Background: TP53 is the most commonly mutated gene in human cancer with loss of function mutations largely concentrated in “hotspots” affecting DNA binding. APR-246 and COTI-2 are small molecules under investigation in P53 mutated cancers.… read more here.

Keywords: apr 246; activity; p53; 246 coti ... See more keywords